Back to
PRIMECAP MANAGEMENT CO/CA/
NKTR5 quarters
Position history for
PRIMECAP MANAGEMENT CO/CA/'s holdings in NEKTAR THERAPEUTICS
Yes. Primecap holds 272,850 shares of NKTR (Nektar Therapeutics), worth $19M, as of its Q2 2026 13F filing. It reduced the position by 6,300 shares (-2.3%) from Q1 2026. Primecap has held NKTR in every 13F on record since Q2 2025, 5 quarterly filings.
Current Value
$19M
Current Shares
272,850
Total Value Change
+$11.3M
Total Shares Change
-26,868
Quarter-by-Quarter History
Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC